Upregulation of Trop-2 quantitatively stimulates human cancer growth

Oncogene

Volumn 32, Issue 2, 2013, Pages 222-233

  Trerotola, M ^a,c   Cantanelli, P ^a   Guerra, E ^a   Tripaldi, R ^a   Aloisi, A L ^a   Bonasera, V ^a   Lattanzio, R ^a   De Lange, R ^b   Weidle, U H ^b   Piantelli, M ^a   Alberti, S ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

cell growth; human tumours; oncogene; signalling; Trop 2

Indexed keywords

MEMBRANE PROTEIN; MESSENGER RNA; PROTEIN TROP 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL GROWTH; CELL TYPE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE MICROSCOPY; MALE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UPREGULATION; WILD TYPE;

ANIMALS; ANTIGENS, NEOPLASM; CALCIUM SIGNALING; CELL ADHESION MOLECULES; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; MCF-7 CELLS; MICE; MICE, NUDE; MUTATION; NEOPLASMS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84872200058     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.36     Document Type: Article

References (59)

1. Fornaro M, Dell'Arciprete R, Stella M, Bucci C, Nutini M, Capri MG et al. Cloning of the gene encoding TROP-2, a cell-surface glycoprotein expressed by human carcinomas. Int J Cancer 1995; 62: 610-618.
2. Ripani E, Sacchetti A, Corda D, Alberti S. The human Trop-2 is a tumor-Associated calcium signal transducer. Int J Cancer 1998; 76: 671-676. (Pubitemid 28243939)
3. Goldstein AS, Stoyanova T, Witte ON. Primitive origins of prostate cancer: In vivo evidence for prostate-regenerating cells and prostate cancer-initiating cells. Mol Oncol 2010; 4: 385-396.
4. Wang J, Day R, Dong Y, Weintraub SJ, Michel L. Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers. Mol Cancer Ther 2008; 7: 280-285. (Pubitemid 351302522)
5. Klein CE, Hartmann B, Schon MP, Weber L, Alberti S. Expression of 38-kD cellsurface glycoprotein in transformed human keratinocyte cell lines, basal cell carcinomas, and epithelial germs. J Invest Dermatol 1990; 95: 74-82. (Pubitemid 20219447)
6. Cubas R, Zhang S, Li M, Chen C, Yao Q. Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway. Mol Cancer 2010; 9: 253.
7. Basu A, Goldenberg DM, Stein R. The epithelial/carcinoma antigen EGP-1, recognized by monoclonal antibody RS7-3G11, is phosphorylated on serine 303. Int J Cancer 1995; 62: 472-479.
8. Trerotola M, Rathore S, Goel HL, Li J, Alberti S, Piantelli M et al. Trop-2 and a2b1 integrin surface receptors as markers of putative human prostate cancer stem cells. Am J Transl Res 2010; 2: 135-144.
9. Fong D, Moser P, Krammel C, Gostner JM, Margreiter R, Mitterer M et al. High expression of TROP2 correlates with poor prognosis in pancreatic cancer. Br J Cancer 2008; 99: 1290-1295.
10. Muhlmann G, Spizzo G, Gostner J, Zitt M, Maier H, Moser P et al. TROP2 expression as prognostic marker for gastric carcinoma. J Clin Pathol 2009; 62: 152-158.
11. Fong D, Spizzo G, Gostner JM, Gastl G, Moser P, Krammel C et al. TROP2: A novel prognostic marker in squamous cell carcinoma of the oral cavity. Mod Pathol 2008; 21: 186-191. (Pubitemid 351172170)
12. Ohmachi T, Tanaka F, Mimori K, Inoue H, Yanaga K, Mori M. Clinical significance of TROP2 expression in colorectal cancer. Clin Cancer Res 2006; 12: 3057-3063. (Pubitemid 43837351)
13. Fang YJ, Lu ZH, Wang GQ, Pan ZZ, Zhou ZW, Yun JP et al. Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer. Int J Colorectal Dis 2009; 24: 875-884.
14. Bignotti E, Todeschini P, Calza S, Falchetti M, Ravanini M, Tassi RA et al. Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. Eur J Cancer 2010; 46: 944-953.
15. Cubas R, Li M, Chen C, Yao Q. Trop2: A possible therapeutic target for late stage epithelial carcinomas. Biochim Biophys Acta 2009; 1796: 309-314.
16. Varughese J, Cocco E, Bellone S, de Leon M, Bellone M, Todeschini P et al. Uterine serous papillary carcinomas overexpress human trophoblast-cell- surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody. Cancer 2011; 117: 3163-3172.
17. Alberti S, Miotti S, Stella M, Klein CE, Fornaro M, Ménard S et al. Biochemical characterization of Trop-2, a cell surface molecule expressed by human carcinomas: Formal proof that the monoclonal antibodies T16 and MOv-16 recognize Trop-2. Hybridoma 1992; 11: 539-535.
18. Klein CEK, Cordon-Cardo C, Soehnchen R, Cote RJ, Oettgen HF, Eisinger M et al. Changes in cell surface glycoprotein expression during differentiation of human keratinocytes. J Invest Dermatol 1987; 89: 500-506. (Pubitemid 17158524)
19. Fradet Y, Cordon-Cardo C, Thomson T, Daly ME, Whitmore Jr WF, Lloyd KO et al. Cell-surface antigens of human bladder cancer defined by mouse monoclonal antibodies. Proc Natl Acad Sci USA 1984; 81: 224-228. (Pubitemid 14180861)
20. Cordon-Cardo C, Bander NH, Fradet Y, Finstad CL, Whitmore WF, Lloyd KO et al. Immunoanatomic dissection of the human urinary tract by monoclonal antibodies. J Histochem Cytochem 1984; 32: 1035-1040. (Pubitemid 14047332)
21. Lipinski M, Parks DR, Rouse RV, Herzenberg LA. Human trophoblast cell-surface antigens defined by monoclonal antibodies. Proc Natl Acad Sci USA 1981; 78: 5147-5150. (Pubitemid 12229690)
22. Trerotola M, Guerra E, Alberti S. Letter to the editor: Efficacy and safety of anti-Trop antibodies. Biochim Biophys Acta 2010; 1805: 119-120.
23. Lal A, Lash AE, Altschul SF, Velculescu V, Zhang L, McLendon RE et al. A public database for gene expression in human cancers. Cancer Res 1999; 59: 5403-5407. (Pubitemid 29526444)
24. Carletti E, Guerra E, Alberti S. The forgotten variables of DNA array hybridization. Trends Biotechnol 2006; 24: 443-448. (Pubitemid 44374779)
25. Nakashima K, Shimada H, Ochiai T, Kuboshima M, Kuroiwa N, Okazumi S et al. Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma. Int J Cancer 2004; 112: 1029-1035. (Pubitemid 39507010)
26. Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR et al. Gene expression profiles in normal and cancer cells. Science 1997; 276: 1268-1272. (Pubitemid 27227367)
27. Maetzel D, Denzel S, Mack B, Canis M, Went P, Benk M et al. Nuclear signalling by tumour-Associated antigen EpCAM. Nat Cell Biol 2009; 11: 162-171.
28. Sukhthankar M, Alberti S, Baek SJ. Epigallocatechin-3-Gallate (EGCG) post-transcriptionally and post-translationally suppresses the cell proliferative protein TROP2 in human colorectal cancer cells. Anticancer Res 2010; 30: 2497-2503.
29. Alberti S, Bucci C, Fornaro M, Robotti A, Stella M. Immunofluorescence analysis in flow cytometry: Better selection of antibody-labeled cells after fluorescence overcompensation in the red channel. J Histochem Cytochem 1991; 39: 701-706.
30. Alberti S, Parks DR, Herzenberg LA. A single laser method for subtraction of cell autofluorescence in flow cytometry. Cytometry 1987; 8: 114-119. (Pubitemid 17046480)
31. Guerra E, Trerotola M, Dell' Arciprete R, Bonasera V, Palombo B, El-Sewedy T et al. A bi-cistronic Cyclin D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer. Cancer Res 2008; 68: 8113-8121.
32. Thorgeirsson UP, Turpeenniemi-Hujanen T, Williams JE, Westin EH, Heilman CA, Talmadge JE et al. NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice. Mol Cell Biol 1985; 5: 259-262. (Pubitemid 15164294)
33. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70. (Pubitemid 30046295)
34. El-Sewedy T, Fornaro M, Alberti S. Cloning of the mouse Trop2 gene -Conservation of a PIP2-binding sequence in the cytoplasmic domain of Trop-2. Int J Cancer 1998; 75: 324-331.
35. Solimini NL, Luo J, Elledge SJ. Non-oncogene addiction and the stress phenotype of cancer cells. Cell 2007; 130: 986-988. (Pubitemid 47422308)
36. Wang J, Zhang K, Grabowska D, Li A, Dong Y, Day R et al. Loss of trop2 promotes carcinogenesis and features of epithelial to mesenchymal transition in squamous cell carcinoma. Mol Cancer Res 2011; 9: 1686-1695.
37. Zanna P, Trerotola M, Vacca G, Bonasera V, Palombo B, Guerra E et al. Trop-1 is a novel cell growth stimulatory molecule that marks early stages of tumor progression. Cancer 2007; 110: 452-464. (Pubitemid 47121907)
38. Dai C, Whitesell L, Rogers AB, Lindquist S. Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell 2007; 130: 1005-1018. (Pubitemid 47410269)
39. Naquet P, Lepesant H, Luxembourg A, Brekelmans P, Devaux C, Pierres M. Establishment and characterization of mouse thymic epithelial cell lines. Thymus 1989; 13: 217-226. (Pubitemid 20077109)
40. Alberti S, Herzenberg LA. DNA methylation prevents transfection of genes for specific surface antigens. Proc Natl Acad Sci USA 1988; 85: 8391-8394. (Pubitemid 19024982)
41. Orsulic S, Li Y, Soslow RA, Vitale-Crosss LA, Gutkind JS, Varmus HE. Induction of ovarian cancer by defined multiple genetic changes in a mouse model system. Cancer Cell 2002; 1: 53-62. (Pubitemid 41039176)
42. Erba E, Ubezio P, Pepe S, Vaghi M, Marsoni S, Torri W et al. Flow cytometric analysis of DNA content in human ovarian cancers. Br J Cancer 1989; 60: 45-50. (Pubitemid 19187744)
43. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 89: 5547-5551.
44. No D, Yao TP, Evans RM. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci USA 1996; 93: 3346-3351. (Pubitemid 26125622)
45. Wolter S, Mushinski JF, Saboori AM, Resch K, Kracht M. Inducible expression of a constitutively active mutant of mitogen-Activated protein kinase kinase 7 specifically activates c-JUN NH2-terminal protein kinase, alters expression of at least nine genes, and inhibits cell proliferation. J Biol Chem 2002; 277: 3576-3584. (Pubitemid 34953229)
46. Alberti S, Fornaro M. Higher transfection efficiency of genomic DNA purified with a guanidinium-thiocyanate-based procedure. Nucleic Acids Res 1990; 18: 351-353.
47. Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmer C, Lubbert H et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 1996; 93: 10933-10938. (Pubitemid 26333095)
48. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494-498. (Pubitemid 32494397)
49. Chalk AM, Wahlestedt C, Sonnhammer EL. Improved and automated prediction of effective siRNA. Biochem Biophys Res Commun 2004; 319: 264-274. (Pubitemid 38670189)
50. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550-553. (Pubitemid 34408678)
51. Alberti S, Nutini M, Herzenberg LA. DNA methylation prevents the amplification of TROP1, a tumor associated cell surface antigen gene. Proc Natl Acad Sci USA 1994; 91: 5833-5837. (Pubitemid 24188236)
52. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T et al. Large-scale analysis of the human and mouse transcriptomes. PNAS 2002; 99: 4465-4470. (Pubitemid 34286008)
53. Bonasera V, Alberti S, Sacchetti A. Protocol for high-sensitivity/long linear-range spectrofluorimetric DNA quantification using ethidium bromide. BioTechniques 2007; 43: 173-176. (Pubitemid 47255050)
54. Querzoli P, Pedriali M, Rinaldi R, Lombardi AR, Biganzoli E, Boracchi P et al. Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients. Clin Cancer Res 2006; 12: 6696-6701. (Pubitemid 44876837)
55. Polishchuk RS, Polishchuk EV, Marra P, Alberti S, Buccione R, Luini A et al. Correlative light-electron microscopy reveals the saccular-tabular ultrastructure of carriers operating between the Golgi apparatus and the plasma membrane. J Cell Biol 2000; 148: 45-58. (Pubitemid 30046781)
56. Brown WJ, Farquhar MG. Immunoperoxidase methods for the localization of antigens in cultured cells and tissue sections by electron microscopy. Methods Cell Biol 1989; 31: 553-569.
57. Tomayko MM, Reynolds CP. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 1989; 24: 148-154. (Pubitemid 19163397)
58. Rossi C, Di Lena A, La Sorda R, Lattanzio R, Antolini L, Patassini C et al. Intestinal tumour chemoprevention with the antioxidant lipoic acid stimulates the growth of breast cancer. Eur J Cancer 2008; 44: 2696-2704.
59. Shi L, Campbell G, Jones WD, Campagne F, Wen Z, Walker SJ et al. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol 2010; 28: 827-838.